Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study - Publication - Bridge of Knowledge

Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study

Abstract

Citations

6 5 4

CrossRef
0

Web of Science
6 8 6

Scopus

Authors (23)

Stephan Stilgenbauer
Barbara Eichhorst
Johannes Schetelig
Steven Coutre
John Seymour
Talha Munir
Soham Puvvada
Clemens-Martin Wendtner
Andrew Roberts
Wojciech Jurczak MD, PhD, Prof
Stephen Mulligan
Sebastian Böttcher
Mehrdad Mobasher
Ming Zhu
Monali Desai
Brenda Chyla
Maria Verdugo
Sari Enschede
Elisa Cerri
Rod Humerickhouse
Gary Gordon
Michael Hallek
William Wierda

Cite as

Full text

full text is not available in portal

full content of the article see on external site open in new tab

Details

Category:: Magazine publication
Type:: Magazine publication
Published in:: LANCET ONCOLOGY no. 17, edition 6, pages 768 - 778,
ISSN: 1470-2045
ISSN:: 1470-2045
Publication year:: 2016
DOI:: Digital Object Identifier (open in new tab) 10.1016/s1470-2045(16)30019-5
Verified by:: No verification

seen 114 times